中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2799条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Petrini, Mario;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Ferreri, Andres Jose Maria;  Damaj, Gandhi Laurent;  Liu, Hui;  Zhang, Wei;  Ke, Xiaoyan;  Ghiggi, Chiara;  Huang, Sha;  Li, Xiaotong;  Yao, Hui;  Paik, Jason;  Noveotny, William;  Zhou, Wenxiao;  Zhu, Hongji;  Zinzani, Pier Luigi
收藏  |  浏览/下载：28/0  |  提交时间：2023/11/10
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文
CANCER MEDICINE, 2022
作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan;  Jin, Jianan;  Zhang, Xiaoyan;  Ma, Tonghui;  Song, Zhengbo
收藏  |  浏览/下载：44/0  |  提交时间：2022/12/23
EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome  
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载：44/0  |  提交时间：2022/12/22
Neoadjuvant  immunotherapy  immune-checkpoint inhibitors  non-small cell lung cancer (NSCLC)  
Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  Wu, Y. -L.;  Zhou, Q.;  Chen, M.;  Pan, Y.;  Jian, O.;  Hu, D.;  Lin, Q.;  Wu, G.;  Cui, J.;  Chang, J.;  Cheng, Y.;  Huang, C.;  Liu, A.;  Yang, N.;  Gong, Y.;  Zhu, C.;  Ma, Z.;  Fang, J.;  Chen, G.;  Zhao, J.;  Shi, A.;  Lin, Y.;  Li, G.;  Liu, Y.;  Wang, D.;  Wu, R.;  Xu, X.;  Shi, J.;  Liu, Z.;  Wang, J.;  Yang, J.
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
CCRT  sCRT  PD-L1 inhibitor  
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Lou, Ge;  An, Ruifang;  Zhang, Guonan;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Zheng, Hong;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Hao, Min;  Huang, Yi;  Lin, Zhongqiu;  Wang, Dong;  Guo, Xiaoqing;  Yao, Shuzhong;  Wan, Xiaoyun;  Zhou, Huaijun;  Yao, Liangqing;  Yang, Xielan;  Cui, Heng;  Meng, Yuanguang;  Zhang, Songling;  Qu, Jing;  Zhang, Ben;  Zou, Jianjun;  Wu, Lingying
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/22
Review on recent progress in on-line monitoring technology for atmospheric pollution source emissions in China 期刊论文
Journal of Environmental Sciences, 2022
作者:  Wang HQ(王焕钦)
Adobe PDF(1568Kb)  |  收藏  |  浏览/下载：81/46  |  提交时间：2022/12/26
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis  
EAST steady-state long pulse H-mode with core-edge integration for CFETR 期刊论文
NUCLEAR FUSION, 2022, 卷号: 62
作者:  Gong, X. Z.;  Garofalo, A. M.;  Huang, J.;  Qian, J. P.;  Ekedah, A.;  Maingi, R.;  Holcomb, C. T.;  Liu, F. K.;  Zhao, Y. P.;  Xiao, B. J.;  Hu, J. S.;  Hu, C. D.;  Hu, L. Q.;  Wang, M.;  Xu, H. D.;  Li, E.;  Zeng, L.;  Zang, Q.;  Liu, H. Q.;  Lyu, B.;  Yuan, Q. P.;  Li, K. D.;  Zhang, B.;  Zhang, J. Y.;  Jia, T. Q.;  Wu, M. Q.;  Chen, J. L.;  Zhu, X.;  Li, M. H.;  Zhang, X. J.;  Zhang, L.;  Duan, Y. M.;  Wang, L.;  Ding, R.;  Sun, Y. W.;  Xu, G. S.;  Liang, Y. F.;  Xiang, N.;  Wan, B. N.;  Li, J. G.
收藏  |  浏览/下载：43/0  |  提交时间：2022/12/23
steady state  long pulse  tokamak  
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Sun, Yan;  Hu, Chaosu;  Lin, Qin;  Gao, Li;  Wang, Jianhua;  Zhu, Xiaodong;  Hao, Junfang;  Lang, Jin Yi;  Wang, Peiguo;  Ye, Ming;  Li, Xia;  Xu, Benhua;  Wu, Rong;  Bai, Chunmei;  You, Qingshan;  Chen, Xiaozhong;  Wang, Jun;  Hu, Desheng;  Wu, Gang;  Pan, Jian-Ji
收藏  |  浏览/下载：31/0  |  提交时间：2022/12/23
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文
LIVER CANCER, 2022, 卷号: 11
作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu;  Jiang, Liming;  Bi, Feng;  Chen, Minshan;  Cheng, Shuqun;  Chi, Yihebali;  Han, Yue;  Huang, Jing;  Huang, Zhen;  Ji, Yuan;  Jia, Liqun;  Jiang, Zhichao;  Jin, Jing;  Jin, Zhengyu;  Li, Xiao;  Li, Zhiyu;  Liang, Jun;  Liu, Lianxin;  Liu, Yunpeng;  Lu, Yinying;  Lu, Shichun;  Meng, Qinghua;  Niu, Zuoxing;  Pan, Hongming;  Qin, Shukui;  Qu, Wang;  Shao, Guoliang;  Shen, Feng;  Song, Tianqiang;  Song, Yan;  Tao, Kaishan;  Tian, Aiping;  Wang, Jianhua;  Wang, Wenling;  Wang, Zhe;  Wu, Liqun;  Xia, Feng;  Xing, Baocai;  Xu, Jianming;  Xue, Huadan;  Yan, Dong;  Yang, Lin;  Ying, Jianming;  Yun, Jingping;  Zeng, Zhaochong;  Zhang, Xuewen;  Zhang, Yanqiao;  Zhang, Yefan;  Zhao, Jianjun;  Zhou, Jianguo;  Zhu, Xu;  Zou, Yinghua;  Dong, Jiahong;  Fan, Jia;  Lau, Wan Yee;  Sun, Yan;  Yu, Jinming;  Zhao, Hong;  Zhou, Aiping;  Cai, Jianqiang
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus